HNGE
Hinge Health, Inc. (NYSE)
Healthcare — Health Information Services
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
Buy
1.6 / 5
15 analysts
$85.07
+$2.07 (+2.49%)
Target:
$82.07
(-3.5%)
Sign in to add HNGE to a watchlist or set price alerts.
Price History
52-Week Range
Fundamentals
| Market Cap | $6.58B |
| P/E Ratio (TTM) | - |
| Forward P/E | 25.12 |
| EPS (TTM) | $-8.92 |
| Dividend Yield | - |
| Profit Margin | -78.95% |
| Revenue Growth | 47.20% |
| ROE | -136.00% |
| Debt/Equity | 2.24 |
| Recommendation | Buy 1.6 |
| Analyst Target | $82.07 |
| Analysts | 15 |
| Indexes | NYSE |
Technical Indicators
| RSI (14) | 93.0 |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $86.66 |
| 52-Week Low | $30.08 |
| 50-Day Avg | $58.77 |
| 200-Day Avg | $48.63 |
| Avg Volume | $1.74M |
| Volume | $1.84M |
Performance Analysis
NEUTRALHNGE presents a mixed picture with both positive and negative indicators.
-
Trading near its 52-week high ($86.66), which may indicate limited upside.
-
RSI at 93.0 indicates overbought conditions — a pullback may be due.
+
Price is above both the 50-day and 200-day moving averages — strong uptrend.
+
Strong revenue growth of 47.2% year-over-year.
-
Operating at a loss with -78.9% margin.
+
Wall Street consensus is "Buy" from 15 analysts.
-
Average analyst target of $82.07 implies 3.5% downside.
Recent News
Loading news...
Last updated: Jul 02, 2026 13:13 UTC
Back to Screener Export Report